Skip to main content
OpenTrials

Clinical trial condition

Purpura, Thrombocytopenic

Explore clinical trials studying Purpura, Thrombocytopenic. Study availability and eligibility vary by location and protocol.

340 public trials 90 recruiting studies
Refine in advanced search Browse all conditions

Purpura, Thrombocytopenic trial results

Completed

Interventional Study in Adults With Immune Thrombocytopenia Purpura (ITP) Receiving Romiplostim

NCT01143038

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Research Site Anaheim, California, United States
  • Research Site Orange, California, United States
  • Research Site Boynton Beach, Florida, United States
  • Research Site Bethesda, Maryland, United States
View all 48 locations
View Trial Details
Completed

Multicentre, Randomised Phase III Study of the Efficacy and Safety of Hetrombopag Olamine in Idiopathic Thrombocytopenic Purpura (ITP) Patient

NCT03222843

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Union Hospital Tongji Medical College Huazhong University of Science and technology Wuhan, Hubei, China
  • West China Hospital，Sichuan University Chengdu, Sichuan, China
  • Hospital of Blood Diseases, Chinese Academy of Medical Sciences Tianjin, Tianjin Municipality, China
View Trial Details
Completed

Long-term Study of Romiplostim in Thrombocytopenic Pediatric Patients With Immune Thrombocytopenia (ITP)

NCT02279173

Conditions
Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
Locations
  • Research Site Roseville, California, United States
  • Research Site Atlanta, Georgia, United States
  • Research Site Chicago, Illinois, United States
  • Research Site Peoria, Illinois, United States
View all 78 locations
View Trial Details
Completed

Follow-up Study for Patients Who Completed Study ALX0681-C301 (Post-HERCULES)

NCT02878603

Conditions
Acquired Thrombotic Thrombocytopenic Purpura, Blood Coagulation Disorders, Blood Platelet Disorders, +14 more
Locations
  • Investigator site St Louis, Missouri, United States
  • Investigator site Valhalla, New York, United States
  • Investigator Site Durham, North Carolina, United States
  • Investigator Site Columbus, Ohio, United States
View all 45 locations
View Trial Details

Related conditions